Johnny Mahlangu to Thrombotic Microangiopathies
This is a "connection" page, showing publications Johnny Mahlangu has written about Thrombotic Microangiopathies.
Connection Strength
0,370
-
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Lancet Haematol. 2023 Mar; 10(3):e168-e177.
Score: 0,212
-
Bispecific Antibody Emicizumab for Haemophilia A: A Breakthrough for Patients with Inhibitors. BioDrugs. 2018 Dec; 32(6):561-570.
Score: 0,159